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Abstract
Coxiella burnetii is a Gram-negative obligate parasitic bacterium that causes the disease Q-
fever in humans. To establish its intracellular niche, it utilizes the Icm/Dot type IVB secretion
system (T4BSS) to inject protein effectors into the host cell cytoplasm. The host targets of
most cognate and candidate T4BSS-translocated effectors remain obscure. We used the
yeast Saccharomyces cerevisiae as a model to express and study six C. burnetii effectors,
namely AnkA, AnkB, AnkF, CBU0077, CaeA and CaeB, in search for clues about their role
inC. burnetii virulence. When ectopically expressed in HeLa cells, these effectors displayed
distinct subcellular localizations. Accordingly, GFP fusions of these proteins produced in
yeast also decorated distinct compartments, and most of them altered cell growth. CaeA
was ubiquitinated both in yeast and mammalian cells and, in S. cerevisiae, accumulated at
juxtanuclear quality-control compartments (JUNQs) and insoluble protein deposits (IPODs),
characteristic of aggregative or misfolded proteins. AnkA, which was not ubiquitinated,
accumulated exclusively at the IPOD. CaeA, but not AnkA or the other effectors, caused
oxidative damage in yeast. We discuss that CaeA and AnkA behavior in yeast may rather
reflect misfolding than recognition of conserved targets in the heterologous system. In con-
trast, CBU0077 accumulated at vacuolar membranes and abnormal ER extensions, sug-
gesting that it interferes with vesicular traffic, whereas AnkB associated with the yeast
nucleolus. Both effectors shared common localization features in HeLa and yeast cells. Our
results support the idea that C. burnetii T4BSS effectors manipulate multiple host cell tar-
gets, which can be conserved in higher and lower eukaryotic cells. However, the behavior
of CaeA and AnkA prompt us to conclude that heterologous protein aggregation and proteo-
static stress can be a limitation to be considered when using the yeast model to assess the
function of bacterial effectors.
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Introduction
Coxiella burnetii, a Gram-negative obligate intracellular bacterial species is a widespread zoo-
notic pathogen which causes the Q-fever syndrome in humans. A variety of wild and domestic
birds, fish and mammals act as reservoirs in the epidemiologic cycle of this pathogen [1]. Infec-
tion in humans is produced after the inhalation of contaminated aerosols, generated by domes-
tic livestock activities. Symptomatic acute Q-fever manifests as a flu-like illness, usually self-
limiting. However, occasionally, chronic Q-fever can develop and evolve into a more serious
disease, often involving endocarditis or hepatitis [2].
C. burnetii expresses a type IVB secretion system (T4BSS) homologous to the Dot/Icm sys-
tem of phylogenetically related Legionella pneumophila [3]. C. burnetii uses its T4BSS to deliver
virulence factors into the host cell cytoplasm, where they interplay with host cell signaling
pathways, thus adapting the host physiology to the demands of the infecting pathogen. A
major key to virulence lies in the fact that this manipulation occurs within professional phago-
cytes in the host, such as macrophages, leading to the survival and replication of bacteria in the
‘parasitophorous vacuole’ [4]. This compartment shares features with phagolysosomes, but is
inefficient in digesting the bacteria. The identification and functional study of the translocated
bacterial effectors involved is an important challenge for the understanding of C. burnetii biol-
ogy and the molecular determinants of disease.
C. burnetii is fastidious to manipulate genetically, although important advances have been
made in the latest years [5]. Hence, great part of the knowledge derives from genetic analyses
of Legionella pneumophila as alternative host to screen for possible Dot/Icm-translocated can-
didates, supported by bioinformatics to identify putative effectors [6]. Functional studies in
alternative eukaryotic model organisms as counterfeit hosts by means of heterologous expres-
sion is also a widespread approach to understand the function of bacterial translocated effec-
tors. The budding yeast Saccharomyces cerevisiae, in virtue of its ease of manipulation and the
impressive amount of knowledge about its biology, has been widely exploited [7]. We have pre-
viously used this model to infer functional traits of translocated effectors from Salmonella
enterica ser. Typhimurium [8–10] and enteropathogenic E. coli [10]. Other researchers have
exploited yeast to study effectors from several pathogens, including obligate intracellular Chla-
mydia trachomatis [11] and, recently, C. burnetii [12–14]. Thus, the yeast system has stood out
as a powerful tool to study bacterial effector proteins. As such proteins target eukaryotic path-
ways, they often lead to traceable effects on yeast.
Here we report expression of a set of C. burnetii proteins in S. cerevisiae as a platform for
their study, and discuss its validity. We chose to express three C. burnetii proteins with
ankyrin repeat domains, AnkA, AnkB and AnkF [15, 16] as well as the anti-apoptotic effec-
tors CaeA and CaeB [17] and a novel candidate effector, CBU0077. Although ankyrin
repeats are common structural domains in eukaryotic cells, including yeast, the molecular
function and interactions of this C. burnetii-secreted protein set remains obscure. Interest-
ingly, CaeA (CBU1524) and CBU0077 had already been shown to inhibit yeast growth
[6, 13], suggesting interference with conserved eukaryotic pathways, although their localiza-
tion had not been determined. In some cases, like those of AnkA and CaeA, the observed
activity in yeast seemed to derive from stress induced by protein aggregation, which might
be unrelated to the function of the effector protein in the actual context of infection. The
localization of ectopically expressed effectors in protein quality control compartments
seems to reveal an important limitation of the yeast model. Nevertheless, effectors of yet
unknown function, like AnkB and CBU0077, are shown to localize in yeast and higher cells
similarly, which might lay the path to dissect the molecular mechanism of these C. burnetii
proteins.
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Materials and Methods
Bacterial and yeast strains, media and growth conditions
Bacterial genes were amplified from genomic DNA from C. burnetii Nine Mile phase II clone
4. S. cerevisiae strains used were YPH499 (MATa ade 2–101 trp1-63 leu2-1 ura3-52 his3-200
lys2-801) and BY4741 (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) for general purposes; and
VHY87 (MATα leu2-3, 112 ura3-52 his4 can1R TRP1::DsRed-HDEL), a gift of M. Cyert, (Stan-
ford University, CA, USA) for the visualization of the ER. The whole genome deletion (WGD)
collection of S. cerevisiae in the BY4741 strain (EUROSCARF) was used to pick out particular
mutants, likemca1Δ::kanMX4 or functionally-oriented subcollections when necessary. The E.
coli strain DH5α F0(K12Δ(lacZYA-argF)U169 deoR supE44 thi-1 recA1 endA1 hsdR17 gyrA96
relA1 (ϕ80lacZΔM15)F0) was used for molecular biology techniques.
YPD (1% yeast extract, 2% peptone and 2% glucose) broth or agar was the general nonselec-
tive medium used for growing yeast. For plasmid selection and maintenance, synthetic complete
medium (SC) contained 0.17% yeast nitrogen base without amino acids, 0.5% ammonium sul-
fate, and 2% glucose, and was supplemented with appropriate amino acids and nucleic acid
bases. SCGal and SCRaf media were SC with 2% galactose or raffinose, respectively, instead of
glucose. Induction of genes under the GAL1 promoter was achieved by growing cells in SCRaf
broth to log phase and then adding galactose from a 20% (w/v) stock solution to a final concen-
tration of 2% and incubating for 5–8 h at 28–30°C.
For assessment of growth on solid media, 5 μl of cell suspensions at OD600 = 0.5 of fresh
transformants from preinocula grown overnight in SC lacking uracil, leucine or tryptophan, as
required, were spotted onto SC or SCGal plates, also lacking the appropriate auxotrophic selec-
tion markers. The original and three serial 1/10 dilutions were deposited for each clone ana-
lyzed and growth was recorded after 2 (glucose) or 3 days (galactose) at 28–30°C (standard
conditions) or 37°C (thermal stress).
Molecular biology techniques and plasmid construction
The pEGFP vectors and pCMV-HA were from Clontech (Mountain View, CA, USA). To clone
ankA, ankB, ankF, CBU0077, caeA and caeB, the genes were amplified by PCR from genomic
DNA of C. burnetiiNMII strain; ankA, ankF, caeA, caeB and CBU0077 were cloned into
pEGFP-C2; ankBwas cloned into pEGFP-C1. The following primers were used: AnkA-EcoRI-F
(5´-ccggatccatggcgtgcaggggaatc-3´), AnkA-BamHI-R (5´-aaggatccttaaaa
cagtccggggcct-3´), AnkB-PstI-F (5´-ccctgcagtatgtttaaccaattggaaatagt-
3´), AnkB-KpnI-R (5´-ccggtaccttacatgtgcttacccggg-3´), AnkF-PstI-F (5´-
cccctgcagtatgagacagcgtgaaattaat-3´), AnkF-BamHI-R (5´-aaggatccc
taccgctggaagccgc-3´). The CaeA and CaeB constructs [17] and the CBU0077 [6] con-
struct are described elsewhere. Additionally CBU0077 was cloned into pCMV-HA with the
primers: CBU0077-BglII-F (5´-ccagatctgcatgagacaactcgtttcaattaa-3´) and
CBU0077-KpnI-R (5´-ccggtaccttacataatagaacacccacga-3´). pEGFP-C1-hPKCθ
was kindly provided by S. Ghosh (Columbia University, NY, USA). To clone ankA, ankB, ankF,
CBU0077, caeA and caeB into the yeast expression pYES2-GFP plasmid, these genes were ampli-
fied by PCR from pEGFP-AnkA, -AnkB, -AnkF, -CBU0077, -CaeA and -CaeB plasmids respec-
tively. The primers used for these amplifications were AnkA-UP (5’-ggaattcccttgcag
ttggcagcccg-3’) and AnkA-LO (5’-gctcta gattaaaacagtccggggcc-3’),
AnkB-UP (5’-ggaattcccatgtttaaccaattg gaaa-3’) and AnkB-LO (5’-gctcta
gattacatgtgcttacccg-3’), AnkF-UP (5’-ggaattcccatgagacagcgtgaaat
taat-3’) and AnkF-LO (5’-gctctagactaccgctggaagccg-3’), CBU0077-UP
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(5’-ggaattcccatgagacaactcgtttca-3’) and CBU0077-LO (5’-gctctagatta
cataatagaacaccca-3’), CaeA-UP (5’-cgggatccatgaacacaagtcctacatc-3’)
and CaeA-LO (5’-ggaattcttaatgatgatgatgatgatgtgtccttttgggagc-3’), and
CaeB-UP (5’-cgggatccttggcaggcatagctg-3’) and CaeB-LO (5’-cgggatcct
tacttattaaattcgggtatg-3’) respectively. The upper primers used to amplify ankA,
ankB, ankF, CBU0077 and caeA had EcoRI and the lower primers XbaI sites. caeB upper and
lower primers carried a BamHI restriction site. PCR products were cleaved with EcoRI and XbaI
or BamHI, respectively, to be inserted into the same restriction sites of the pYES2-GFP plasmid
[18], generating pYES2-GFP-AnkA, pYES2-GFP-AnkB, pYES2-GFP-AnkF,
pYES2-GFP-CBU0077, pYES2-GFP-CaeA and pYES2-GFP-CaeB plasmids. To obtain pEG
(KG)-AnkB, expressing GST-AnkB, ankB was amplified with the AnkB-KG-UP (5’-gctcta
gacatgtttaaccaattggaa-3’) and AnkB-LO (as above) primers, both of them containing
the XbaI restriction site, using pYES2-GFP-AnkB as a template. The PCR product was cleaved
with XbaI and inserted into the same site in the pEG(KG) vector [19]. The pEG(KGH)-AnkB
was obtained by subcloning the ankB-containing XbaI-XbaI fragment from pEG(KG)-AnkB
into the same site of the pEG(KGH) plasmid, a pEG(KG) plasmid in which the URA3marker
has been substituted by theHIS3marker [20]. The GAL-YBH3 overexpression plasmid was
obtained from a yeast genomic collection (Dharmacon, GE Healthcare). pGILDA-Bax was a gift
of J.L. Revuelta (Univ. Salamanca, Spain). pESC-LEU-CHFP-Ubq9ts and p425-GAL1-RNQ1-m-
Cherry [21] were kindly provided by D. Kaganovich (Hebrew University of Jerusalem, Israel).
The NOP1-mCherry construct (pUN100-mCherry-NOP1) [22] was a gift of Olivier Gadal (Uni-
versité de Toulouse, France). Yeast transformation by the lithium acetate method were per-
formed by standard methods
Microscopy techniques
For fluorescence microscopy of GFP-expressing live yeast cells, log-phase cultures were har-
vested by centrifugation, washed once with sterile water and viewed directly. In vivo DAPI
staining was performed by adding DAPI (Sigma) resuspended in PBS at a final concentration
of 10 μgml−1 to cells and incubating for 5 min. To detect vacuolar and endosomal compart-
ments, staining with FM4-64 was performed, as described by Vida and Emr [23]. For statistical
significance of data,100 cells were examined for each condition or experiment and triplicate
biological replicas were analyzed. Cells were examined under an Eclipse TE2000U microscope
(Nikon, Tokyo, Japan) and digital images were acquired with an Orca C4742-95-12ER charge-
coupled-device camera (Hamamatsu Photonics, Hamamatsu City, Japan) and HCImage
software. Confocal images were taken using an Olympus FV1200 system (Olympus, Tokyo,
Japan).
Immunodetection in yeast extracts by Western blotting
Standard procedures were used for yeast cell growth, collection, breakage, protein separation
by SDS-PAGE, and transfer to nitrocellulose membranes [24]. GFP fusion proteins were
detected using monoclonal anti-GFP antibodies (Living Colors, JL-8) diluted 1:2000. GST
fusions were immunodetected with primary rabbit polyclonal anti-GST (Z-5) antibody (Santa
Cruz Biotechnology) diluted 1:2000. Ubiquitin residues were detected using monoclonal anti-
ubiquitin antibody (P4G7; Abcam) diluted 1:2000. Secondary antibodies were IRDye-680 or
IRDye -800 anti-rabbit or anti-mouse antibodies (Li-Cor Biosciences), or Alexa-680 anti-
mouse (Invitrogen) and detection was performed with an Odyssey Infrared Imaging System
(LI-COR Biosciences).
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Evaluation of cell death and oxidative damage by flow cytometry
For the analysis of cellular lysis, oxygen-free radicals (ROS) and variations of the mithocondrial
membrane potential, yeast transformants were grown in SCRaf medium lacking uracil at 30°C
overnight. Then, the cultures were induced by galactose addition to a 2% final concentration
for 16 h. Propidium iodide (0.005%), dihydroethidium (2.5 μg/ml for 5 min) or rhodamine 123
(5 μg/ml for 2h) were added; the samples with propidium iodide were diluted 1:10 in PBS.
Three thousand cells were analysed per second on a FACScan flow cytometer (Becton Dickin-
son) on the FL2 log scale. WinMDI 2.7 software was used to handle the graphics obtained.
Sensitivity assays
Yeast sensitivity or resistance to different compounds was tested by a halo assay on agar plates.
Transformants bearing plasmids expressing each of the Coxiella proteins or the control empty
vector were grown and OD600 adjusted to 1. Then, cultures were swabbed uniformly across a
SCGal agar plate. A 6 mm cellulose disk, impregnated with the compound to be tested, was
then placed on the surface of the agar and plates were incubated for 3 days at 30°C. The diame-
ters of the inhibition haloes were recorded and compared to the corresponding control halos
obtained with yeast transformed with the pYES2-GFP empty vector. The compounds and con-
centrations used were the following: amphotericin B (30 mM), benomyl (25 mM), geneticin
(10 mM), menadione (10 mM), hygromycin B (50 mM), latrunculin B (2.5 mM), myriocin
(12.5 mM), miconazol (50 mM), rapamycin (2.5mM), tunicamycin (10 mM), cyclosporine A
(50 mM), hydroxyurea (50 mM), orthovanadate (50 mM) and neomycin sulfate (100 and 200
mM).
For the determination of dose-response curves, yeast transformants carrying the GAL1-pro-
moter bearing plasmid pYES2GFP (empty vector) or pYES2GFP-AnkB were cultured in the
appropriate SCRaf medium until log-phase. These preinocula were then diluted into fresh
SCRaf to an OD600 of 0.5. Then, 5 μL of the suspension were seeded into 96-well microplates
containing 100 μL SCGal to induce the expression of the heterologous proteins. Previously,
hygromycin B, neomycin sulfate or rapamycin were added in two-fold serial dilutions to the
plates. Plates were then incubated at 30°C and OD600 was measured at 0, 24, and 48 h in a spec-
trophotometer for 96-well plates (model 680; Bio-Rad, Hercules, CA).
HeLa cells transfection, fluorescence microscopy and immunoblotting
HeLa human epithelial cell lines were cultured at 37°C in 5% CO2 in Dulbecco modified Eagle
medium (Life Technologies) containing 10% heat-inactivated fetal bovine serum (Biochrom)
and 1% penicillin-streptomycin (Life Technologies). Cells were plated on coverslips and were
transfected with pEGFP-derived plasmids expressing C. burnetii genes using Xtreme Gene 9
transfection reagent from Roche. Eighteen hours post-transfection, cells were fixed with 4%
paraformaldehyde (Alfa Aeser) in PBS (Biochrom), permeabilized with ice-cold methanol, and
quenched with 50mMNH4Cl (Roth) in PBS. Samples were incubated with the following pri-
mary antibodies: anti-tubulin (Sigma, diluted 1:100), anti-calnexin (Stressgen, 1:100) and anti-
LAMP1 H4A3 (Developmental Studies Hybridoma Bank, 1:250); and the following secondary
antibodies: Alexa Fluor 488 and Alexa Fluor 594 (Life Technologies, 1:600). Cells were
mounted using ProLong Diamond with DAPI (Life Technologies) to visualize the nucleus. For
mitochondrial staining, cells were incubated using Mitotracker Red CMXRos (Molecular
Probes) before fixation according to the manufacturer protocol. Confocal fluorescence micros-
copy was performed using a Zeiss LSM 700 confocal microscope.
Ectopic expression of GFP, GFP-AnkA, GFP-AnkB, GFP-CaeA, GFP-CaeB and
GFP-CBU77 in transiently transfected HeLa cells was analyzed with rabbit anti-GFP (Life
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Technologies, 1:3000) and anti-α-tubulin (Sigma, 1:5000) antibodies as loading control.
Lysate preparation, SDS-PAGE and transfer to PVDF membranes were performed by stan-
dard procedures. Proteins were visualized by using horseradish peroxidase-conjugated sec-
ondary antibodies (Dianova, 1:5000) and a chemiluminescence detection system (Thermo
Scientific or Millipore).
Ubiquitination Assays
Ubiquitination assays in yeast cells were performed by pulling down GST or GST-CaeA from
yeast lysates as described [8], followed by immunoblotting with monoclonal anti-ubiquitin
antibodies (ab24686, Abcam) diluted 1:1000. Ubiquitination assays in mammalian cells were
performed as described [25]. Briefly, HEK293T cells were transfected in 6-well plates with 1 μg
of the pEGFP-derived plasmids and 2 μg of an HA-ubiquitin expressing vector (Addgene plas-
mid # 18712; a gift from Edward Yeh [26]) or pcDNA3.1 (Life Technologies) as a negative con-
trol, using XtremeGene 9 transfection reagent. Eighteen hours post-transfection, cells were
treated for 4 h with 20 μM of the proteasome inhibitor MG132. The positive control (PKCθ)
was additionally stimulated with 25 nM PMA 45 min before harvesting the cells in 200 μl boil-
ing SDS lysis buffer (20 mM Tris-HCl, 1% SDS, pH 8.0). After boiling and shearing the DNA
by ultrasonication, the protein concentration was normalized and 400 μg of total protein were
immunoprecipitated overnight in 1 ml TNT buffer (1% Triton X-100, 150 mMNaCl, 20 mM
Tris-HCl, 1 mM EDTA, 0.5% NP-40) using 1 μg of rabbit anti-GFP antibody (Life Technolo-
gies) and Protein A/G Plus-Agarose (Santa Cruz Biotechnology). Beads were washed exten-
sively and samples were blotted and probed with rabbit anti-GFP (Life Technologies, 1:3000)
and mouse anti-HA (HA.11 Clone 16B12, Covance, 1:1000) as primary antibodies. Chemilu-
miniscent detection was carried out as above.
Results
Ectopic expression of the C. burnetii effector proteins AnkA, AnkB,
AnkF, CaeA, CaeB and CBU0077 in HeLa cells
To evaluate the soundness of S. cerevisiae as a model to study the putative host cell targets of
C. burnetii T4BSS effectors, we studied in parallel the expression of N-terminal GFP-tagged
fusions in both transfected cell lines and yeast. First, we determined their intracellular locali-
zation in the human cell line HeLa. As shown in Fig 1A, the different C. burnetii effector
proteins displayed distinct subcellular localization patterns when ectopically expressed.
GFP-AnkA partially co-localized with tubulin (see detailed images in S1 Fig), GFP-AnkB dis-
played nuclear localization, and GFP-AnkF exhibited both cytoplasmic and nuclear localiza-
tion. Although GFP-CaeA localized diffusely to the nucleus, as reported earlier [6], in
roughly 40% of the GFP-CaeA-expressing cells this protein was observed at multiple bright
nuclear punctate dots. Finally, CaeB co-localized with the ER marker calnexin. The localiza-
tion of HA-tagged AnkA, AnkB, AnkF, CaeA and CaeB, was identical to the GFP-tagged ver-
sions (data not shown). However, interestingly, the localization of CBU0077 depended on
the fusion tag. Thus, GFP-CBU0077 was shown to localize to the mitochondria, while
HA-CBU0077 rather co-localized with the lysosomal marker protein LAMP-1 (Fig 1A), in
agreement with the previous report that localization of FLAG-CBU0077 was lysosomal [6].
Expression of the GFP-fusion proteins was analyzed using immunoblot analysis (Fig 1B).
Notably, GFP-AnkA, -AnkF, -CaeA, -CaeB and -CBU0077 were stably expressed, while
GFP-AnkB showed some degradation.
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Expression of C. burnetii AnkA, AnkB, CBU0077 and CaeA proteins in
S. cerevisiae negatively affects cell growth
Next, the ORFs encoding AnkA, AnkB, AnkF, CBU0077, CaeA and CaeB were cloned in frame
with GFP in a GAL1 promoter-driven vector, to be expressed in S. cerevisiae specifically in the
Fig 1. Expression of C. burnetii T4BSS-translocated effectors in mammalian HeLa cells. (A) Immunofluorescence confocal images show the
representative subcellular localization of the indicated GFP- or HA-taggedC. burnetii effector proteins (green) after ectopic expression in HeLa cells. For
contrast, DAPI, Mitotracker, or anti-tubulin, anti-calnexin and anti-LAMP-1 antibodies, were used as marked. Scale bars represent 10mm. (B) Expression of
the indicated GFP-tagged C. burnetii effectors was analyzed by immunoblot analysis. Protein extracts from transfected HeLa cells were separated by
SDS-PAGE, transferred to PVDFmembrane and probed with anti-GFP antibody and anti-tubulin as loading control. A representative immunoblot is shown
out of three independent experiments with similar results.
doi:10.1371/journal.pone.0148032.g001
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presence of galactose as carbon source. Growth in galactose was assessed, as compared to con-
trol conditions in glucose, where the promoter is subjected to catabolic repression. As shown in
Fig 2A, all proteins were efficiently expressed in yeast. GFP-AnkA, GFP-AnkB, GFP-CBU0077
and GFP-CaeA led to significant growth inhibition at different degrees, both on solid and liq-
uid media (Fig 2B and 2C), while GFP-AnkF and GFP-CaeB did not (Fig 2B). Moderate growth
inhibition of S. cerevisiae by CBU077 and CaeA is consistent with previous data [6, 13]. The
ankA, ankB, ankF and caeA genes were additionally expressed as N-terminal GST fusions,
leading to the same results (S2 Fig). Given that a large tag may be masking functional domains
or result in altered intracellular localization, as shown for ectopic expressed CBU0077 in HeLa
cells (Fig 1), some effectors were also expressed as C-terminal tagged fusions to poly-His. Both
CBU0077 and CaeA failed to induce toxicity in yeast when expressed as C-terminal poly-His
tagged proteins (S2 Fig), in contrast to the N-terminal GFP/GST fusions, implying that toxicity
or subcellular targeting of these proteins in yeast depended on their free C-terminal ends.
Incubation of C. burnetii effector-expressing yeast transformants at 37°C, a suitable temper-
ature for the study of the molecular properties of human pathogens, but a heat-stress tempera-
ture for yeast, did not generally alterthe effects on growth caused by the assayed C. burnetii
effectors (S2 Fig). An exception was GFP-AnkB, which was unable to inhibit yeast growth at
this temperature. These observations suggested that AnkB is less stable at this temperature in
yeast cells. Accordingly, the amount detected by immunoblot on lysates incubated at 37°C was
greatly diminished (data not shown). GST-AnkB, however, maintained toxicity (S1 Fig), prob-
ably due to the fact that the pEG(KG) vector used imposes a higher expression level that the
one used for GFP fusions. A summary of results obtained with the different fusions tested is
provided in S1 Table.
CaeA induces oxidative stress and apoptosis in the yeast cell
Cae effectors have previously been related to the inhibition of apoptotic pathways in the host
cell [15, 17, 27, 28]). In yeast however, CaeA expression was shown to be toxic (Fig 1B and [13,
28]). To determine the molecular mechanism(s) behind this activity, we tested whether loss of
selective permeability of the plasma membrane (propidium iodide-positive cells), loss of mito-
chondrial membrane potential (MMP; rhodamine-positive cells) or production of reactive oxy-
gen species (ROS; dihydroethidium-positive cells), which are markers related to cell death [29],
were enhanced or reduced upon expression of C. burnetii effectors in yeast. Except for CaeA,
none of the expressed effectors led to significant alterations in the parameters monitored by
these markers, in spite of their toxicity (Fig 3A). Expression of CaeA led to cell death, loss of
MMP and production of ROS at similar levels than overproduction of either YBH3, a pro-apo-
ptotic S. cerevisiae BCL-2 Homology domain 3 (BH3)-containing protein [30] or heterologous
mammalian Bax [31] (Fig 3B). In contrast, caeA expression did not counteract the apoptotic
effects induced by either co-expression of Bax (Fig 3B) or acetic acid treatment (S3 Fig). Rather,
the deleterious effects caused by CaeA were additive to those of acetic acid, as in the case of
Ybh3 and Bax (S3 Fig). Thus, in yeast, unlike in higher cells, caeA expression does not protect
the cell from apoptotic damage, but leads to oxidative damage in a fashion reminiscent of pro-
apoptotic factors.
CaeA is ubiquitinated and primarily stored at JUNQ compartments in
yeast
Next we investigated whether subcellular localization of heterologous GFP-CaeA in yeast cells
could provide clues for its toxicity or the induction of oxidative damage and apoptotic cell
death shown above. As shown in Fig 4A, GFP-CaeA localized at one or two spots per cell,
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rather than in many smaller spots, as observed in a subpopulation of HeLa cells (see Fig 1A).
Simultaneous staining with DAPI to visualize the nucleus and FM4-64 as a marker of endocytic
pathway suggested that one of the spots was always associated to the nucleus (100% of GFP-
positive cells; n = 300), whereas the second spot, usually less intense, was rather associated to
the yeast vacuole (100% of cells with two GFP-CaeA spots; n = 300) (Fig 4A). Confocal micros-
copy of DAPI-stained yeast cells confirmed that the only CaeA-labeled spot, or the most
intense when two spots were present, was intimately associated, but never overlapping, with
nuclear DNA (Fig 4B). Co-expression of a DsRed fusion to the endoplasmic reticulum (ER)
localization signal HDEL [32], which readily marks the perinuclear and peripheric ER, showed
that the brightest spot was always (100% of GFP-positive cells, n = 300) engulfed by the peri-
nuclear ER, confirming its intimate association with the nucleus (Fig 4C). The observed
GFP-CaeA localization was consistent with the juxtanuclear quality-control (JUNQ), also
known as intranuclear quality control (INQ), and the perivacuolar insoluble protein deposit
(IPOD) compartments, recently described in yeast and mammalian cells [21, 33]. These com-
partments were first observed in yeast upon heterologous expression of the von Hippel-Lindau
(VHL) tumor suppressor protein or a thermosensitive allele of the SUMO ligase Ubc9 [21]. A
feature of these compartments is that they are retained at the mother cell during the budding
cycle, so that the newborn daughter does not inherit damaged or defective proteins [34]. Thus,
we determined whether medium- and large-budded cells showed fluorescent GFP-CaeA spots
either in the daughter or in the mother cell. Out of 300 budding cells observed by fluorescence
microscope, 100% displayed GFP fluorescent spots only in the mother cells, whereas not a sin-
gle bud was observed to host these GFP-CaeA-marked compartments. Furthermore, co-
expression of Ubc9ts-DsRed and GFP-CaeA demonstrated that one of the spots, the most con-
spicuous, corresponded to the JUNQ (Fig 4D). Actually, when only one spot per cell of
GFP-CaeA was observed, it always co-localized with Ubc9ts-DsRed, suggesting that the JUNQ
is the primary destination of the CaeA protein in yeast. Furthermore, CaeA expression seemed
not only to localize but to induce the formation of JUNQs/INQs, as Ubc9ts-DsRed spots could
Fig 2. Expression of C. burnetii T4BSS-translocated effectors in yeast. (A) Immunoblot with anti-GFP antibodies on yeast lysates from transformants of
YPH499 strain with pYES2-GFP-derived plasmids expressing the indicated GFP-tagged C. burnetii effector proteins grown on SCRaf selective medium and
induced for 4 h by addition of galactose. (B) Serial dilution drop assays to monitor growth under induction (Galactose) and control (Glucose) conditions of
representative transformants as in (A). (C) Growth in liquid SCGal medium of yeast transformants expressing the indicated GFP fusions after 36 h of growth
in 96-well plates. Data are the average of 36 wells per experiment, corresponding to three different transformant clones (12 wells per clone), and are
expressed in percentage with respect to the control transformed with the empty vector (average O.D.600 of control samples was considered 100% growth).
Bars correspond to the standard deviation. P-values noted were determined by the Student’s T-test.
doi:10.1371/journal.pone.0148032.g002
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be appreciated in cells incubated at permissive temperature that expressed GST- or GFP-CaeA,
but not in those expressing GST or GFP from the empty vectors (data not shown). Moreover,
CaeA-(His)6, which is not toxic for yeast, did not induce Ubc9ts-DsRed cytoplasmic aggregates
either (data not shown), suggesting that a free C-terminal end is required for CaeA to induce
protein aggregation. Co-expression of the IPOD marker Rnq1-DsRed demonstrated that the
second, less intense, GFP-CaeA spot either overlayed or was surrounded by this marker (Fig
4E). Thus, interestingly, the IPOD seems to accumulate the excess of CaeA when the JUNQ is
saturated
Nucleus-associated JUNQs, but not perivacuolar IPODs, have been reported to store ubi-
quitinated unfolded proteins [21]. Interestingly, GFP-CaeA showed slow mobility bands in
immunoblots on yeast lysates (Fig 2A). To test whether CaeA was ubiquitinated in yeast cells,
we expressed GST-CaeA, purified the fusion protein by glutathione affinity chromatography
and immunoblotted the pulled down proteins with anti-ubiquitin antibodies. Indeed, the slow
mobility bands corresponded to ubiquitinated CaeA forms (Fig 5), likely representing the frac-
tion of protein stored at the JUNQ.
CaeA has a variable series of Glu-Lys (EK) repeats that might account for autoaggregation
properties or act as ubiquitination target sequence. We expressed a mutant version lacking the
EK repeats (caeAΔ49–61) but it behaved as wild type caeA in terms of toxicity, post-transla-
tional modifications, accumulation in JUNQ/IPOD compartments and triggering MMP
Fig 3. CaeA behaves like apoptotic inducers Ybh3 and human Bax in yeast. (A) CaeA expression induces oxidative stress. The graph represents the
enhancement of positive YPH499 yeast cells expressing the indicatedC. burnetii effector proteins from the correspondingGAL1-driven expression vectors,
as determined by flow cytometry, expressed as times-fold over control cells transformed with the empty vector. The fluorochromes propidium iodide (white
bars), rhodamine 123 (grey bars) and dihydroethidium (black bars), respectively monitor cell death, altered mitochondrial potential and intracellular ROS
accumulation in the yeast populations.GAL1-driven YBH3 overexpression on the same strain was used as a positive control. Data correspond to a
representative experiment of triplicate replicas. (B) Flow cytometry histograms of representative experiments as in (A) on YPH499 transformants expressing
the indicated proteins from the correspondingGAL1-driven expression vectors. The gating threshold is marked by a vertical line. The percentage of cells in
the population beyond the gating threshold is shown for each histogram.
doi:10.1371/journal.pone.0148032.g003
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Fig 4. GFP-CaeA primarily accumulates at JUNQs, and residually at IPODs in yeast cells. (A)
Fluorescence microscopy of GFP-CaeA-expressing yeast cells counterstained with DAPI and FM4-64 to
visualize respectively nuclei and vacuoles. YPH499 cells transformed with pYES2-GFP-CaeA were induced
in galactose for 6 h. Filled white arrowheads point to the nucleus-associated spot, normally the most intense;
hollow arrowheads indicate the less intense vacuole-associated spot. (B) A prominent GFP-CaeA spot is
associated to the nucleus. Confocal microscopy of representative cells displaying one only (left) or two (right)
GFP-CaeA spots, as indicated. DAPI, which marks nuclear and mitochondrial DNA, is shown in red color for
better contrast with green GFP-CaeA. The relative position of GFP-CaeA spots to nuclear DNA for each cell
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depolarization and ROS production (S4 Fig). Thus, this region is dispensable for the effects of
CaeA in the yeast cell.
CaeA is poly-ubiquitinated in mammalian cells
To test whether CaeA is also ubiquitinated in mammalian host cells, we transfected HEK293
cells with GFP-CaeA and HA-ubiquitin and performed a co-immunoprecipitation assay. As a
positive control we used GFP-PKCθ and as negative control GFP. As demonstrated in Fig 5B.
Both GFP-CaeA and GFP-PKCθ were efficiently poly-ubiquitinated, while GFP was not. This
result implies that the ubiquitination of CaeA is conserved in yeast and mammalian cells.
AnkA accumulates at yeast IPOD compartments
In view of the results obtained with CaeA, we investigated whether other C. burnetii effectors
found to be toxic in yeast were equally targeted to these compartments. No co-localization with
JUNQs was observed (data not shown), but GFP-AnkA did accumulate at single large vacuole-
associated spots (Fig 6A). These spots were marked by Rnq1-DsRed (Fig 6B), suggesting their
nature as IPODs. Thus, GFP-AnkA localizes differently in yeast and mammalian cells, proba-
bly due to aggregation and/or misfolding in yeast, as in the case of CaeA. Given that no oxida-
tive or apoptotic markers were detected by expression of AnkA, and its toxicity for the yeast
cell was milder than that of CaeA, it is likely that accumulation of unfolded proteins at the
JUNQ, but not at the IPOD is related to the high toxicity of CaeA in yeast.
CBU0077 localizes to the vacuole and abnormal ER membranes in
yeast
As shown above, in mammalian cells localization of CBU0077 depends on the fusion tag.
Thus, GFP-CBU0077 decorated mitochondria, whereas FLAG- and HA-tagged CBU0077 co-
localized with the lysosomal LAMP-1 marker (Fig 1 and [6]). When expressed in yeast,
76.33 ± 2.31% of the cells displayed GFP-CBU0077 at the vacuolar membrane, an equivalent to
lysosomes in mammalian cells, as shown by staining with the endocytic marker FM4-64 (Fig
7A). However, other cytoplasmic structures, usually in the shape of bars that were not stained
by FM4-64, were also labeled with GFP-CBU0077 (Fig 7A). Co-expression with HDEL-DsRed
probe revealed that these structures corresponded to ER membranes. A very high proportion
(95.66 ± 1.53%) of cells with GFP-CBU0077 signal showed alterations in the ER shape and
organization (see representative cells in Fig 7B), as compared with GFP-negative cells (marked
with a white arrow in the upper panel of Fig 7B), which display the normal ER morphology
reported by using this probe [32]. Such alterations involved the lack of a homogeneous peri-
nuclear and plasma membrane-associated ER, the appearance of cytoplasmic bars and
is depicted in the schemes at the bottom. (C) Representative micrograph of a pYES2-GFP-CaeA
transformant of strain VHY87, bearing an integrated marker for the ER (HDEL-DsRed). The filled white
arrowhead indicates the GFP-CaeA spot engulfed by the perinuclear ER, and the hollow arrowhead shows
the spot located in the cytoplasm beyond the perinuclear ER. (D) Co-localization of GFP-CaeA (green) with
the JUNQmarker Ubc9ts-DsRed (red). YPH499 yeast cells were co-transformed with pYES2-GFP-CaeA
and pESC-LEU-CHFP-Ubq9ts and induced in galactose for 4 h. The GFP-CaeA positive cell in the upper part
of the picture shows a representative cell with one single GFP-CaeA spot, which corresponds to the JUNQ
(white filled arrowhead). In cells in which a second, less intense spot appears, it shows no co-staining with
Ubc9Ts (hollow arrowhead, bottom cell). (E) Co-localization of GFP-CaeA (green) with the IPODmarker
Rnq1 (red). YPH499 yeast cells were co-transformed with pYES2-GFP-CaeA and
p425-GAL1-RNQ1-mCherry, and induced as in C. The second, less intense, GFP-CaeA spot is clearly
associated to the Rnq1 marker. As in panels (C) and (D), filled white arrowheads point at GFP-CaeA at
JUNQs, whereas empty arrows mark IPODs. Bars represent 5 μm in all panels.
doi:10.1371/journal.pone.0148032.g004
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disorganized structures, and enhancement of perinuclear signal. Thus, interestingly, CBU0077
expression co-localizes with and distorts the yeast ER.
AnkB localizes to the yeast nucleus, and is associated to the nucleolus
Similar to its localization when ectopically expressed in HeLa cells, GFP-AnkB localized to the
yeast nucleus, as confirmed by DAPI staining (Fig 7C). Moreover, GFP-AnkB signal was
enriched at a particular kidney-shaped spot within the nucleus. Co-expression of a marker for
the yeast nucleolus, Nop1-mCherry, indicated that GFP-AnkB invariably concentrated at the
nucleolus or in close proximity to it (Fig 7C). Remarkably, nuclear localization of AnkB in
yeast is consistent with that observed when ectopically expressed in HeLa cells (see Fig 1A),
Fig 5. CaeA is ubiquitinated in yeast andmammalian cells. (A) GST-CaeA was affinity purified from
YPH499 cell lysates expressing the fusion protein from pEG(KG)-CaeA after 6h-galactose induction. A
transformant with the empty plasmid expressing GST alone were analyzed in parallel as a control. Original
inputs (Lysate) and the result of affinity purification on glutathione-coated beads (Pull-down) were solved by
SDS-PAGE, transferred to a nitrocellulose membrane, and immunoblotted with both anti-GST (left) and anti-
ubiquitin (right) antibodies, as indicated. (B) HEK293T cells were co-transfected with plasmids expressing the
indicated GFP-fusion proteins and HA-ubiquitin. GFP-tagged proteins were immunoprecipitated (IP) with a
rabbit anti-GFP antibody. Lysates and IPs were solved by SDS-PAGE, transferred to a PVDFmembrane,
and immunoblotted with both anti-GFP (top) and anti-HA antibodies (bottom).
doi:10.1371/journal.pone.0148032.g005
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strongly suggesting that AnkB undergoes nuclear translocation when produced in eukaryotic
cells.
AnkB alters yeast sensitivity to aminoglycosides
Next we studied whether heterologous expression of C. burnetii effectors caused cellular stress
in the yeast cell. A study on the activation of yeast stress-induced MAPK signaling pathways
related to mammalian Erk- and p38-mediated routes was performed by immunoblotting yeast
lysates with two antibodies that specifically recognize the activated dually phosphorylated form
of either MAPKs Slt2, Fus3 and Kss1 or the MAPK Hog1. No evidence of interference of any of
the C. burnetii proteins with these pathways was found (data not shown). To gain insight into
the mechanisms leading to toxicity in yeast, we exposed cells expressing C. burnetii effectors to
a battery of compounds targeting different processes in the cell, namely the antifungals ampho-
tericin B and miconazole, the cytoskeleton polymerization inhibitors latrunculin and benomyl,
TORC inhibitor rapamycin, myriocin, tunicamycin, menadione and aminoglycoside antibiot-
ics, by a halo sensitivity assay on solid medium. As a result, we found that expression of
GFP-AnkB, but not the other effectors, affected yeast sensitivity to aminoglycosides, like neo-
mycin sulfate and hygromycin B (Fig 8A). Sensitivity of AnkB-expressing cells to neomycin
was further confirmed by a dose-response curve (Fig 8B).
Discussion
The difficulties of working with obligate parasitic bacteria such as C. burnetii in mammalian
cells make the development of model systems necessary. The yeast S. cerevisiae has been used
to study virulence factors from different bacterial pathogens and, very recently, it has been
Fig 6. Localization of GFP-AnkA to the yeast IPOD compartment. (A) YPH499 transformants expressing GFP-AnkA (green) from the pYES2-GFP-AnkA
plasmid after induction in galactose for 4 h were incubated with FM4-64 (red) for 30 min to allow visualization of the vacuolar membrane. (B) YPH499 yeast
cells were co-transformed with pYES2-GFP-AnkA and p425-GAL1-RNQ1-mCherry, an induced as above. Representative cells are shown of two typical
patterns: neat co-localization of both red and green channels (upper panel) and inclusion of the green GFP-AnkA signal within a larger Rnq1-mCherry
compartment (lower panel). Bars represent 5 μm.
doi:10.1371/journal.pone.0148032.g006
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Fig 7. Localization of CBU0077 and AnkB in yeast cells. (A) GFP-CBU0077 is associated to yeast vacuolar membranes. Fluorescence microscopy of
YPH499 transformants expressing GFP-CBU0077 (green) from the pYES2-based expression vector and induced with galactose for 4 h prior to incubation
with FM4-64 (red) as in Fig 5A. Arrowheads mark vacuoles with membranes clearly marked in both channels. (B) GFP-CBU0077 accumulates at abnormal
cytoplasmic structures that harbor the ERmarker HDEL. Fluorescence microscopy of pYES2-GFP-CBU0077 transformants of strain VHY87, constitutively
expressing the ERmarker HDEL-DsRed. The filled arrowhead in the upper panel points to a cell lacking GFP signal, serving as a visual reference for a
typical yeast ER shape (red channel) consisting of neat perinuclear and plasma-membrane associated membranes. This pattern is typically distorted in the
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applied to the characterization of several type IVB secretion system effectors from C. burnetii
[6, 12, 13]. Here we exploit this model as a tool to study six particular effector proteins from
this bacterium. In this context, the expression of most C. burnetii effectors tested inhibited
yeast growth to a different extent, including CaeA, which has been described as a T4BSS pro-
survival effector in higher cells [17]. This controversial finding was consistent with previous
reports [6, 13], so we focused on understanding the effects of CaeA on yeast cells. Paradoxi-
cally, CaeA in yeast rather behaved as a pro-apoptotic effector, altering mitochondrial mem-
brane potential, increasing cell lysis, promoting generation of ROS, and exacerbating the effect
of pro-apoptotic agents or proteins in yeast. Furthermore, we observed that GFP-CaeA was
partially ubiquitinated. Interestingly, this result was extrapolated to higher cells, where ectopi-
cally expressed GFP-CaeA was also found to undergo ubiquitination. It remains to be eluci-
dated whether this post-transcriptional modification might be important for function. Our
results suggest that ubiquitinated CaeA is stored at JUNQ/INQ in yeast cells, in agreement
with the notion that misfolded proteins that accumulate at the JUNQ are generally ubiquiti-
nated, whereas those destined to the IPOD are not [21]. Therefore, the partial ubiquitination of
CaeA is consistent with its localization in both types of compartments, although it seems to
preferentially accumulate at JUNQs. Such localization of CaeA is likely due to a folding defect
in the heterologous system. The sustained proteostatic stress generated by the overexpression
of a foreign protein might account for the observed enhancement in oxidative stress markers
and general toxicity of CaeA on the yeast cell. However, not all of the C. burnetii effectors
adjacent cell, showing high GFP-CBU0077 signal. In the middle panel, a characteristic cell in which some of the cytoplasmic bar-shaped cytoplasmic
structures containing GFP-CBU0077 (green) co-localize with the ERmarker (hollow arrowhead). In the lower panel, the arrowhead indicates a characteristic
cell with a high expression level of GFP-CBU0077 strongly associated with the perinuclear ER. (C) Localization of AnkB to the yeast nucleus and association
with the nucleolar compartment. YPH499 cells were co-transformed with pYES2-GFP-AnkB and pUN100-mCherry-NOP1, induced in galactose for 4h, co-
stained with DAPI to counterstain nuclei and observed by fluorescence microscopy. Representative fields are shown displaying cells at different stages of the
mitotic cycle. The GFP-AnkB signal (green) is enriched within the yeast nucleus at a spot either overlapping or adjacent to the mCherry-Nop1 nucleolar
marker. Bars correspond to 5 μm in all panels.
doi:10.1371/journal.pone.0148032.g007
Fig 8. AnkB expression enhances S. cerevisiae sensitivity to aminoglycosides. (A) Graph displaying the measurements of the growth inhibition halo
(mm) around a 6 mm-disc (horizontal line) soaked with a solution of the hygromycin B or neomycin sulfate concentrations indicated on YPH499 cells bearing
pYES2-GFP-AnkB or the empty vector as a control. Data are the average of five (hygromycin B) or two (neomycin) independent experiments performed on
different transformants. (B) Dose-response curve showing the effect of½ serial dilutions of neomycin on growth of YPH499 transformants bearing
pYES2-GFP-AnkB or the empty vector, as a control, cultured in SCGal liquid medium. Data are the average or three biological replicates, each performed on
an individual transformant clone. Asterisks denote statistical significance of data (*) p<0.05; (**) p<0.01; (***) p<0.005. P-values were calculated by the
Student’s T-test.
doi:10.1371/journal.pone.0148032.g008
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causing toxicity in yeast end up in protein quality control compartments. Among the T4BSS
substrates other than CaeA assayed here, only AnkA accumulated in IPODs, underscoring the
idea that extra toxicity of CaeA could be related to its specific accumulation at the JUNQ.
Although our results in yeast likely reflect a consequence of overexpression of the heterolo-
gous protein, the fact that CaeA partially accumulates in discrete punctate spots in mammalian
cells might indicate that ectopically expressed CaeA could also be destined to yet undescribed
protein quality control compartments. Peculiarly, only a very limited number of overproduced
proteins have been reported to display this behaviour in yeast, so it might reflect structural
properties intrinsic to CaeA. In consequence, CaeA could be potentially utilized as a tool to
study protein quality control and ubiquitin-dependent sorting pathways in yeast.
In mammalian cells, some differences in the localization of ectopically expressed effectors
were observed that differ with previous reports. For example, AnkA and AnkB were shown by
Voth et al. [35] to be cytoplasmic. Here, GFP-AnkA is indeed found at the cytoplasm, although
in a reticular pattern, partially associated with tubulin. AnkB, however, is neatly concentrated
in the nucleus, although we cannot discard that this localization does not correspond to the
full-length protein, but to a major C-terminal truncated form that may result from proteolysis,
as suggested by immunoblot analysis. Divergence with previous reports may be due to the
experimental choice of different fusions and C. burnetii strains. CaeB was previously reported
to be associated to a mitochondrial fraction [6], although its localization in a later report was
suggestive of wider cytoplasmic membrane networks [17], in consistence with the co-localiza-
tion with the ER calnexin marker here shown.
CBU0077 is a translocated C. burnetii effector of yet unknown function [36], which had
been previously reported to interfere with yeast growth [6]. Inside the host cell, C. burnetii sur-
vives and replicates within compartments named C. burnetii-containing vacuoles (CCV). The
CCV fuses with vesicles bearing early and late endosomal, as well as lysosomal markers. Even-
tually, the CCV enlarges drastically, even occupying almost the entire volume of the host cell
[37]. The formation of the large mature CCV requires interaction with ER membranes through
the early secretory pathway [38]. The modulation of such trafficking events is probably orches-
trated by C. burnetii effectors, as bacterial protein production is required for the development
of the large CCV [39]. Addressing the localization of C. burnetii effectors in the yeast model
should provide preliminary clues on their putative interaction with eukaryotic intracellular
membranes. The localization of CBU0077 at the yeast vacuolar membrane, equivalent to
lysosomes in higher cells, as well as at ER membranes, together with the observation that it
dramatically alters the morphology of the yeast ER, might suggest that this effector could be
implicated in CCV formation or maintenance. However, it remains to be determined where
CBU0077 localizes once translocated by C. burnetii during infection, as ectopically expressed
CBU0077 in HeLa cells displayed divergent subcellular localization in lysosomes or mitochon-
dria depending on the fusion-tag.
The ankyrin repeat-containing protein AnkB, a T4BSS effector of elusive function, localized
to the nucleus in yeast and mammalian cells. In yeast, AnkB mainly concentrated at the nucleo-
lus. Thus, it is likely that it exerts its toxicity on the yeast cell by modulating gene expression or
genome stability. There is limited evidence of bacterial effectors that translocate to the nucleus
and directly modulate nuclear functions in the host cell. Interestingly, such effectors often
seem to contain ankyrin repeats, such as AnkA from Anaplasma phagocytophilum [40, 41].
Yeast cells overexpressing AnkB were more sensitive to aminoglucosides, which might hint
that its interference with nuclear functions negatively affects protein synthesis, perhaps by
altering proper expression of ribosomal genes. In a screen for overexpression suppressors, we
isolated the GCV3 gene, coding for the H-subunit of the yeast mitochondrial glycine decarbox-
ylase complex [42], by its ability to counteract AnkB-induced growth inhibition (data not
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shown). Thus, it is likely that the presence of AnkB at the nucleus perturbs metabolic or mito-
chondrial function. Further studies will be required to elucidate which particular functions are
downregulated by this nuclear translocated effector and whether its nuclear targets are com-
mon to yeast and higher cells.
In sum, heterologous expression in yeast as an approach to understand the interaction of
bacterial translocated effectors with eukaryotic cellular functions may prove helpful [7, 43],
especially when novel effectors are under study. Subcellular localization of heterologous bacte-
rial effectors might provide important clues to preliminarily understand the organelles, path-
ways and functions targeted by these proteins. However, it must be considered that yeast, as a
heterologous model, has severe limitations. Therefore, caution should be taken in the interpre-
tation of results and their extrapolation to higher cells. Here we underscore that some bacterial
effectors accumulate in protein quality control compartments, such as JUNQs or IPODs, a phe-
nomenon that could reflect misfolding or aggregation of the overexpressed protein. Thus, in
these cases, proteostatic stress may significantly contribute to the observed inhibition of yeast
growth, which would not be necessarily related to interference with molecular targets con-
served from yeast to human. In turn, these aggregative proteins might shed light on the yet
obscure mechanisms that govern protein quality control in eukaryotic cells. On the other hand,
in proteins neatly targeting conserved cellular compartments, such as trafficking organelles or
the nucleus, as it is the case of C. burnetii CBU0077 and AnkB, respectively, yeast might pro-
vide useful information on how to orient further analyses in more complex experimental infec-
tion models.
Supporting Information
S1 Fig. GFP-AnkA partially co-localizes with tubulin in HeLa cells. A representative confo-
cal image of a HeLa cell transiently expressing GFP-AnkA, stained with an anti-tubulin anti-
body. Co-localization, as indicated by shades of yellow, was analyzed in four different regions
(1 to 4) of a representative image (scale bar, 10 μm).
(EPS)
S2 Fig. Growth of yeast expressing GFP-/GST-fusions of C. burnetii effectors at both 28
and 37°C. Serial dilution drop assays to monitor growth under induction (Galactose) and con-
trol (Glucose) conditions of yeast cells expressing the indicated proteins incubated for three
days at 28 or 37°C.
(EPS)
S3 Fig. CaeA expression enhances severity of apoptotic stimuli. Flow cytometry histograms
of representative experiments on YPH499 transformants overproducing from GAL1-driven
expression pYES2-GFP-based vectors the proteins indicated, after treatment with 125mM ace-
tic acid. The fluorochromes tested, propidium iodide, rhodamine 123 and dihydroethidium,
respectively cell death, altered mitochondrial potential and intracellular ROS accumulation
indicated in the population, as indicated on top of each column. The gating threshold is
marked by a vertical line. The percentage of cells in the population beyond the threshold is
shown.
(EPS)
S4 Fig. Deletion of the Lys-Glu repetitions of CaeA does not influence the phenotypes
induced in yeast. (A) Immunoblot with anti-GFP antibodies on yeast lysates obtained under
induction conditions showing expression of GFP fusions of the proteins indicated. Transfor-
mant clones of YPH499 strain were grown on SCRaf selective medium and induced for 4 h by
addition of galactose. (B) Serial dilution drop assays to monitor growth under induction
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(Galactose) and control (Glucose) conditions of representative transformant clones expressing
the indicated proteins. (C) GFP-CaeA-Δ49–61 is located at the proximity of the nuclear and
vacuolar compartments, in a fashion identical to wt CaeA. (D) Flow cytometry histograms of
representative experiments on YPH499 transformants overproducing from GAL1-driven
expression vectors the proteins indicated in presence or absence of 125mM acetic acid. The
fluorochromes tested, propidium iodide, rhodamine 123 and dihydroethidium are indicated.
The gating threshold is marked by a vertical line. The percentage of cells in the population over
the threshold is shown.
(EPS)
S1 Table. Summary of observed localization and effects of ectopically expressed C. burnetii
effector fusions.
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